Learning Objectives:

1. Examine the Mechanism of Action and Potential Therapeutic Benefits of GLP-1 Receptor Agonists in IBD: discuss the pharmacological actions of GLP-1 receptor agonists, including their effects on gut motility, and anti-inflammatory properties, and how these mechanisms could potentially benefit IBD management
2. Review Current Research and Clinical Trials Evaluating GLP-1 Receptor Agonists for IBD: analyze the existing literature including preclinical and early-stage clinical trials, that assesses the efficacy and safety of GLP-1 receptor agonists in treating IBD.
3. Discuss the Clinical Implications and Considerations for Using GLP-1 Receptor Agonists in IBD Patients: critically assess the practical utilization GLP-1 receptor agonists in IBD. This will include identifying appropriate patient profiles, considering potential exacerbation of symptoms like diarrhea.